Is Lisdexamfetamine Dimesylate Capsule (Vyvanse) in shortage?

Why it’s in shortage

• Delay in shipping of the drug
• Other
• Shortage of an active ingredient

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

• Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 65162-023-09)
  Amneal PharmaceuticalsIn shortageAvailableUpdated Oct 6, 2026

  Maker contact: 866-525-7270

• Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09)
  Amneal PharmaceuticalsIn shortageAvailableUpdated Oct 6, 2026

  Maker contact: 866-525-7270

• Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 65162-025-09)
  Amneal PharmaceuticalsIn shortageAvailableUpdated Oct 6, 2026

  Maker contact: 866-525-7270

• Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 65162-026-09)
  Amneal PharmaceuticalsIn shortageAvailableUpdated Oct 6, 2026

  Maker contact: 866-525-7270

• Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 65162-027-09)
  Amneal PharmaceuticalsIn shortageAvailableUpdated Oct 6, 2026

  Maker contact: 866-525-7270

• Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 65162-028-09)
  Amneal PharmaceuticalsIn shortageAvailableUpdated Oct 6, 2026

  Maker contact: 866-525-7270

• Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77)
  Mylan Pharmaceuticals Inc., a Viatris CompanyIn shortageAvailableUpdated Oct 5, 2026

  Maker contact: 800-796-9526

• Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77)
  Mylan Pharmaceuticals Inc., a Viatris CompanyIn shortageAvailableUpdated Oct 5, 2026

  Maker contact: 800-796-9526

• Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77)
  Mylan Pharmaceuticals Inc., a Viatris CompanyIn shortageAvailableUpdated Oct 5, 2026

  Maker contact: 800-796-9526

• Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77)
  Mylan Pharmaceuticals Inc., a Viatris CompanyIn shortageAvailableUpdated Oct 5, 2026

  Maker contact: 800-796-9526

• Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77)
  Mylan Pharmaceuticals Inc., a Viatris CompanyIn shortageAvailableUpdated Oct 5, 2026

  Maker contact: 800-796-9526

• Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77)
  Mylan Pharmaceuticals Inc., a Viatris CompanyIn shortageAvailableUpdated Oct 5, 2026

  Maker contact: 800-796-9526

• Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77)
  Mylan Pharmaceuticals Inc., a Viatris CompanyIn shortageAvailableUpdated Oct 5, 2026

  Maker contact: 800-796-9526

• Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01)
  AlvogenIn shortageAvailableUpdated Oct 2, 2026

  Maker contact: 844-842-8672 and email: CustomerService-US@alvogen.com

• Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01)
  AlvogenIn shortageAvailableUpdated Oct 2, 2026

  Maker contact: 844-842-8672 and email: CustomerService-US@alvogen.com

• Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01)
  AlvogenIn shortageAvailableUpdated Oct 2, 2026

  Maker contact: 844-842-8672 and email: CustomerService-US@alvogen.com

• Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01)
  AlvogenIn shortageAvailableUpdated Oct 2, 2026

  Maker contact: 844-842-8672 and email: CustomerService-US@alvogen.com

• Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01)
  AlvogenIn shortageAvailableUpdated Oct 2, 2026

  Maker contact: 844-842-8672 and email: CustomerService-US@alvogen.com

• Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01)
  AlvogenIn shortageAvailableUpdated Oct 2, 2026

  Maker contact: 844-842-8672 and email: CustomerService-US@alvogen.com

• Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01)
  AlvogenIn shortageAvailableUpdated Oct 2, 2026

  Maker contact: 844-842-8672 and email: CustomerService-US@alvogen.com

• Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01)
  Elite Laboratories, Inc.In shortageLimited AvailabilityUpdated Oct 2, 2026

  Estimated recovery: TBD

  Maker contact: 888-852-6657

• Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01)
  Elite Laboratories, Inc.In shortageLimited AvailabilityUpdated Oct 2, 2026

  Estimated recovery: TBD

  Maker contact: 888-852-6657

• Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01)
  Elite Laboratories, Inc.In shortageLimited AvailabilityUpdated Oct 2, 2026

  Estimated recovery: TBD

  Maker contact: 888-852-6657

• Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01)
  Elite Laboratories, Inc.In shortageLimited AvailabilityUpdated Oct 2, 2026

  Estimated recovery: TBD

  Maker contact: 888-852-6657

• Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 64850-554-01)
  Elite Laboratories, Inc.In shortageLimited AvailabilityUpdated Oct 2, 2026

  Estimated recovery: TBD

  Maker contact: 888-852-6657

• Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01)
  Elite Laboratories, Inc.In shortageLimited AvailabilityUpdated Oct 2, 2026

  Estimated recovery: TBD

  Maker contact: 888-852-6657

• Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01)
  Elite Laboratories, Inc.In shortageLimited AvailabilityUpdated Oct 2, 2026

  Estimated recovery: TBD

  Maker contact: 888-852-6657

• Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01)
  Teva Pharmaceuticals USA, Inc.In shortageAvailableUpdated Oct 1, 2026

  Maker contact: 800-545-8800

• Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01)
  Teva Pharmaceuticals USA, Inc.In shortageAvailableUpdated Oct 1, 2026

  Maker contact: 800-545-8800

• Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01)
  Teva Pharmaceuticals USA, Inc.In shortageAvailableUpdated Oct 1, 2026

  Maker contact: 800-545-8800

• Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01)
  Teva Pharmaceuticals USA, Inc.In shortageAvailableUpdated Oct 1, 2026

  Maker contact: 800-545-8800

• Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01)
  Teva Pharmaceuticals USA, Inc.In shortageAvailableUpdated Oct 1, 2026

  Maker contact: 800-545-8800

• Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01)
  Teva Pharmaceuticals USA, Inc.In shortageAvailableUpdated Oct 1, 2026

  Maker contact: 800-545-8800

• Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01)
  Teva Pharmaceuticals USA, Inc.In shortageAvailableUpdated Oct 1, 2026

  Maker contact: 800-545-8800

• Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37)
  Lannett Company, Inc.In shortageAvailableUpdated Oct 1, 2026

  Maker contact: 844-834-0530

• Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37)
  Lannett Company, Inc.In shortageAvailableUpdated Oct 1, 2026

  Maker contact: 844-834-0530

• Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37)
  Lannett Company, Inc.In shortageAvailableUpdated Oct 1, 2026

  Maker contact: 844-834-0530

• Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37)
  Lannett Company, Inc.In shortageAvailableUpdated Oct 1, 2026

  Maker contact: 844-834-0530

• Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37)
  Lannett Company, Inc.In shortageAvailableUpdated Oct 1, 2026

  Maker contact: 844-834-0530

• Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37)
  Lannett Company, Inc.In shortageAvailableUpdated Oct 1, 2026

  Maker contact: 844-834-0530

• Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0527-4667-37)
  Lannett Company, Inc.In shortageAvailableUpdated Oct 1, 2026

  Maker contact: 844-834-0530

• Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25)
  Hikma Pharmaceuticals USA, Inc.In shortageLimited AvailabilityUpdated Sep 18, 2026

  Available on allocation

  Maker contact: 800-631-2174

• Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25)
  Hikma Pharmaceuticals USA, Inc.In shortageLimited AvailabilityUpdated Sep 18, 2026

  Available on allocation

  Maker contact: 800-631-2174

• Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0054-0372-25)
  Hikma Pharmaceuticals USA, Inc.In shortageLimited AvailabilityUpdated Sep 18, 2026

  Available on allocation

  Maker contact: 800-631-2174

• Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25)
  Hikma Pharmaceuticals USA, Inc.In shortageLimited AvailabilityUpdated Sep 18, 2026

  Available on allocation

  Maker contact: 800-631-2174

• Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25)
  Hikma Pharmaceuticals USA, Inc.In shortageLimited AvailabilityUpdated Sep 18, 2026

  Available on allocation

  Maker contact: 800-631-2174

• Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0054-0375-25)
  Hikma Pharmaceuticals USA, Inc.In shortageLimited AvailabilityUpdated Sep 18, 2026

  Available on allocation

  Maker contact: 800-631-2174

• Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88)
  Sun Pharmaceutical Industries, Inc.In shortageLimited AvailabilityUpdated Sep 18, 2026

  Estimated Recovery: TBD

  Maker contact: 800-818-4555

• Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-047-88)
  Sun Pharmaceutical Industries, Inc.In shortageLimited AvailabilityUpdated Sep 18, 2026

  Estimated Recovery: TBD

  Maker contact: 800-818-4555

• Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88)
  Sun Pharmaceutical Industries, Inc.In shortageLimited AvailabilityUpdated Sep 18, 2026

  Estimated Recovery: TBD

  Maker contact: 800-818-4555

• Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88)
  Sun Pharmaceutical Industries, Inc.In shortageLimited AvailabilityUpdated Sep 18, 2026

  Estimated Recovery: TBD

  Maker contact: 800-818-4555

• Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88)
  Sun Pharmaceutical Industries, Inc.In shortageLimited AvailabilityUpdated Sep 18, 2026

  Estimated Recovery: TBD

  Maker contact: 800-818-4555

• Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88)
  Sun Pharmaceutical Industries, Inc.In shortageLimited AvailabilityUpdated Sep 18, 2026

  Estimated Recovery: TBD

  Maker contact: 800-818-4555

• Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1)
  Apotex Corp.In shortageAvailableUpdated Sep 16, 2026

  Maker contact: 800-706-5575

• Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1)
  Apotex Corp.In shortageUnavailableUpdated Sep 16, 2026

  Estimated recovery: 9/25/26

  Maker contact: 800-706-5575

• Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1)
  Apotex Corp.In shortageAvailableUpdated Sep 16, 2026

  Maker contact: 800-706-5575

• Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1)
  Apotex Corp.In shortageAvailableUpdated Sep 16, 2026

  Maker contact: 800-706-5575

• Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)
  Apotex Corp.In shortageAvailableUpdated Sep 16, 2026

  Maker contact: 800-706-5575

• Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1)
  Apotex Corp.In shortageAvailableUpdated Sep 16, 2026

  Maker contact: 800-706-5575

• Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1)
  Apotex Corp.In shortageAvailableUpdated Sep 16, 2026

  Maker contact: 800-706-5575

• Vyvanse, Capsule, 10 mg (NDC 59417-101-10)
  Takeda Pharmaceuticals USA Inc.In shortageAvailableUpdated Sep 15, 2026

  Maker contact: 877-TAKEDA-7 (1-877-825-3327)

• Vyvanse, Capsule, 20 mg (NDC 59417-102-10)
  Takeda Pharmaceuticals USA Inc.In shortageAvailableUpdated Sep 15, 2026

  Maker contact: 877-TAKEDA-7 (1-877-825-3327)

• Vyvanse, Capsule, 30 mg (NDC 59417-103-10)
  Takeda Pharmaceuticals USA Inc.In shortageAvailableUpdated Sep 15, 2026

  Maker contact: 877-TAKEDA-7 (1-877-825-3327)

• Vyvanse, Capsule, 40 mg (NDC 59417-104-10)
  Takeda Pharmaceuticals USA Inc.In shortageAvailableUpdated Sep 15, 2026

  Maker contact: 877-TAKEDA-7 (1-877-825-3327)

• Vyvanse, Capsule, 50 mg (NDC 59417-105-10)
  Takeda Pharmaceuticals USA Inc.In shortageAvailableUpdated Sep 15, 2026

  Maker contact: 877-TAKEDA-7 (1-877-825-3327)

• Vyvanse, Capsule, 60 mg (NDC 59417-106-10)
  Takeda Pharmaceuticals USA Inc.In shortageAvailableUpdated Sep 15, 2026

  Maker contact: 877-TAKEDA-7 (1-877-825-3327)

• Vyvanse, Capsule, 70 mg (NDC 59417-107-10)
  Takeda Pharmaceuticals USA Inc.In shortageAvailableUpdated Sep 15, 2026

  Maker contact: 877-TAKEDA-7 (1-877-825-3327)

• Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01)
  SpecGx LLCIn shortageAvailableUpdated Aug 20, 2026

  Maker contact: 800-325-8888

• Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01)
  SpecGx LLCIn shortageAvailableUpdated Aug 20, 2026

  Maker contact: 800-325-8888

• Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0406-5113-01)
  SpecGx LLCIn shortageAvailableUpdated Aug 20, 2026

  Maker contact: 800-325-8888

• Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0406-5114-01)
  SpecGx LLCIn shortageAvailableUpdated Aug 20, 2026

  Maker contact: 800-325-8888

• Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0406-5115-01)
  SpecGx LLCIn shortageAvailableUpdated Aug 20, 2026

  Maker contact: 800-325-8888

• Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0406-5116-01)
  SpecGx LLCIn shortageAvailableUpdated Aug 20, 2026

  Maker contact: 800-325-8888

• Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0406-5117-01)
  SpecGx LLCIn shortageAvailableUpdated Aug 20, 2026

  Maker contact: 800-325-8888

• Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 43547-602-10)
  Solco Healthcare US, LLCIn shortageLimited AvailabilityUpdated Jun 29, 2026

  On allocation

  Maker contact: 866-931-9829

• Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 43547-603-10)
  Solco Healthcare US, LLCIn shortageLimited AvailabilityUpdated Jun 29, 2026

  On allocation

  Maker contact: 866-931-9829

• Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10)
  Solco Healthcare US, LLCIn shortageLimited AvailabilityUpdated Jun 29, 2026

  On allocation

  Maker contact: 866-931-9829

• Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 43547-605-10)
  Solco Healthcare US, LLCIn shortageLimited AvailabilityUpdated Jun 29, 2026

  On allocation

  Maker contact: 866-931-9829

• Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 43547-606-10)
  Solco Healthcare US, LLCIn shortageLimited AvailabilityUpdated Jun 29, 2026

  On allocation

  Maker contact: 866-931-9829

• Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 43547-607-10)
  Solco Healthcare US, LLCIn shortageLimited AvailabilityUpdated Jun 29, 2026

  On allocation

  Maker contact: 866-931-9829

• Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 43547-608-10)
  Solco Healthcare US, LLCIn shortageLimited AvailabilityUpdated Jun 29, 2026

  On allocation

  Maker contact: 866-931-9829

• Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01)
  Rhodes Pharmaceuticals L.P.In shortageAvailableUpdated Jun 24, 2026

  Maker contact: 888-827-0616

• Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01)
  Rhodes Pharmaceuticals L.P.In shortageLimited AvailabilityUpdated Jun 24, 2026

  Estimated recovery: TBD

  Maker contact: 888-827-0616

• Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 42858-163-01)
  Rhodes Pharmaceuticals L.P.In shortageLimited AvailabilityUpdated Jun 24, 2026

  Estimated recovery: TBD

  Maker contact: 888-827-0616

• Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01)
  Rhodes Pharmaceuticals L.P.In shortageLimited AvailabilityUpdated Jun 24, 2026

  Estimated recovery: TBD

  Maker contact: 888-827-0616

• Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 42858-165-01)
  Rhodes Pharmaceuticals L.P.In shortageLimited AvailabilityUpdated Jun 24, 2026

  Estimated recovery: TBD

  Maker contact: 888-827-0616

• Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 42858-166-01)
  Rhodes Pharmaceuticals L.P.In shortageAvailableUpdated Jun 24, 2026

  Maker contact: 888-827-0616

• Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01)
  Rhodes Pharmaceuticals L.P.In shortageLimited AvailabilityUpdated Jun 24, 2026

  Estimated recovery: TBD

  Maker contact: 888-827-0616

• Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25)
  Hikma Pharmaceuticals USA, Inc.In shortageLimited AvailabilityUpdated May 12, 2026

  Available on allocation

  Maker contact: 800-631-2174

FDA recalls of Lisdexamfetamine Dimesylate

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Lisdexamfetamine Dimesylate Capsule:

• SUN PHARMACEUTICAL INDUSTRIES INC recalls Lisdexamfetamine Dimesylate Capsules, 30 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New
  Oct 28, 2025Class II
• SUN PHARMACEUTICAL INDUSTRIES INC recalls Lisdexamfetamine Dimesylate Capsules, 40 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New
  Oct 28, 2025Class II
• SUN PHARMACEUTICAL INDUSTRIES INC recalls Lisdexamfetamine Dimesylate Capsules, 10 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New
  Oct 28, 2025Class II
• SUN PHARMACEUTICAL INDUSTRIES INC recalls Lisdexamfetamine Dimesylate Capsules, 20 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New
  Oct 28, 2025Class II
• SUN PHARMACEUTICAL INDUSTRIES INC recalls Lisdexamfetamine Dimesylate Capsules, 70 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New
  Oct 28, 2025Class II
• SUN PHARMACEUTICAL INDUSTRIES INC recalls Lisdexamfetamine Dimesylate Capsules, 50 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New
  Oct 28, 2025Class II
• SUN PHARMACEUTICAL INDUSTRIES INC recalls Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New
  Oct 28, 2025Class II
• Lannett Company Inc. recalls Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc.,
  Aug 11, 2025Class II
• SUN PHARMACEUTICAL INDUSTRIES INC recalls Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New
  Jun 16, 2025Class II
• Lannett Company Inc. recalls Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company,
  Oct 25, 2024Class II
• Shire recalls Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc.,
  Sep 2, 2016Class III

Other forms on FDA’s list

• Lisdexamfetamine Dimesylate Tablet, Chewable